Cargando…
Ibrutinib: Rebound effect in the form of respiratory deterioration following the discontinuation of ibrutinib: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062825/ http://dx.doi.org/10.1007/s40278-021-94672-7 |
Ejemplares similares
-
Ibrutinib: Pneumonitis: case report
Publicado: (2021) -
Ibrutinib-induced cardiomyopathy
por: Kyi, Htay Htay, et al.
Publicado: (2019) -
Outcomes with ibrutinib by line of therapy and post‐ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis
por: O'Brien, Susan M., et al.
Publicado: (2019) -
Bortezomib/ibrutinib/rituximab: Various toxicities: case report
Publicado: (2021) -
Ibrutinib: Grade 3 neutropenia and fever: case report
Publicado: (2022)